Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The British Journal of Dermatology
|
July 26, 2017
Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series
H Song, N Lahood, A Mostaghimi
The British Journal of Dermatology
|
September 24, 2019
Post-traumatic stress disorder in patients with autoimmune blistering diseases
E X Wei, S J Li, A Mostaghimi
Lupus
|
May 13, 2009
Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge
M A Kriegel, C Van Beek, A Mostaghimi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 5, 2022
Validation of case identification for hyperpigmentation in the setting of medication use using international classification of diseases coding
N Theodosakis, J Yoon, K Young, et al.
The British Journal of Dermatology
|
February 17, 2018
The validity of the diagnostic code for pyoderma gangrenosum in an electronic database
S J Lockwood, D G Li, D Butler, et al.
The British Journal of Dermatology
|
December 24, 2019
Modelling the value of risk-stratified skin cancer screening of asymptomatic patients by dermatologists
R I Hartman, Y Xue, S Singer, et al.
Applied Clinical Informatics
|
July 15, 2015
Prevalence and Risk Profile Of Unread Messages To Patients In A Patient Web Portal
B H Crotty, A Mostaghimi, J O'Brien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 28, 2023
Investigating the association between gender minority identity and skin cancer prevalence: A cohort study in the United States All of Us research program
K Kamal, K Young, S Ly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 23, 2024
Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2
M Senna, A Mostaghimi, M Ohyama, et al.
ESMO Open
|
June 8, 2026
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer
E Salehi, X Chu, E L Mayer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The British Journal of Dermatology
|
July 26, 2017
Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series
H Song, N Lahood, A Mostaghimi
The British Journal of Dermatology
|
September 24, 2019
Post-traumatic stress disorder in patients with autoimmune blistering diseases
E X Wei, S J Li, A Mostaghimi
Lupus
|
May 13, 2009
Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge
M A Kriegel, C Van Beek, A Mostaghimi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 5, 2022
Validation of case identification for hyperpigmentation in the setting of medication use using international classification of diseases coding
N Theodosakis, J Yoon, K Young, et al.
The British Journal of Dermatology
|
February 17, 2018
The validity of the diagnostic code for pyoderma gangrenosum in an electronic database
S J Lockwood, D G Li, D Butler, et al.
The British Journal of Dermatology
|
December 24, 2019
Modelling the value of risk-stratified skin cancer screening of asymptomatic patients by dermatologists
R I Hartman, Y Xue, S Singer, et al.
Applied Clinical Informatics
|
July 15, 2015
Prevalence and Risk Profile Of Unread Messages To Patients In A Patient Web Portal
B H Crotty, A Mostaghimi, J O'Brien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 28, 2023
Investigating the association between gender minority identity and skin cancer prevalence: A cohort study in the United States All of Us research program
K Kamal, K Young, S Ly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 23, 2024
Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2
M Senna, A Mostaghimi, M Ohyama, et al.
ESMO Open
|
June 8, 2026
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer
E Salehi, X Chu, E L Mayer, et al.
Page
of 2